On-Demand: 2024 NUCLEAR PHARMACY CE
Nuclear Medicine in Pediatrics
Elizabeth Rhoda, PharmD, RPh, Purdue University Nuclear Pharmacy Fellow
Upon completion of this activity, participants will be able to: Recognize commonly used pediatric nuclear medicine studies and protocols; Identify pearls and considerations for pediatric use of radiopharmaceuticals; Summarize key points regarding pediatric radiobiology; Evaluate different dosing methods for pediatrics and calculate correct doses for pediatrics; Explore advantages and challenges with using PET MRI vs PET CT pediatrics.
UAN: 0675-0000-24-031-H01-P/T
Cancer Associated Fibroblast (CAF) and Current Clinical Trial Diagnostic Agents
Garcia Simon Clark, PharmD, MS, ANP, CCP, BCNP, Kindred Healthcare, Pharmacy Supervisor
Upon completion of this activity, participants will be able to: Describe fibroblast activation protein and its role in cancer; Discuss multiple cancer type detection using fibroblast labeled with a radiotracer; Evaluate the clinical trials using fibroblast detection.
UAN: 0675-0000-24-032-H01-P/T
PET on the Mind: Radiopharmaceuticals for Brain Imaging
Elizabeth Rayes, PharmD, Brigham and Women’s Hospital Nuclear Pharmacy, RadioPharmacist
Upon completion of this activity, participants will be able to: Describe Beta-Amyloid and its role in Alzheimer's; Discuss the use of F18 Beta-Amyloid imaging agents; Evaluate clinical trials on the use of tau & microglial radiotracers.
UAN: 0675-0000-24-033-H01-P/T
Germanium 68/Gallium 68 Generator Best Practices
Jay Simon, RPh, ANP, Managing Director North America, Eckert & Zeigler
Upon completion of this activity, participants will be able to: Discuss the methods for production of Gallium 68 to be incorporated into a drug product; Describe the steps of eluting a GalliPharm generator and the process of measuring the Germanium 68 breakthrough; Explain best sterile techniques when eluting the gallium generator either in an ISO 8 or ISO 5 environment.
UAN: 0675-0000-24-034-H01-P/T
Advancements in Pulmonary Imaging – It’s Here – Exploring Technegas
Vesper Grantham, MEd, RT(N), CNMT, Chair, Medical Imaging and Radiation Sciences, Program Director, Nuclear Medicine
Upon completion of this activity, participants will be able to: Describe the protocol features of Technegas including equipment, radiopharmaceutical administration, and imaging protocol; Discuss the advantages of Technegas over traditional ventilation imaging agents; Evaluate implementation of Technegas for nuclear medicine departments.
UAN: 0675-0000-24-035-H01-P/T
The U.S. Nuclear Regulatory Commission (NRC) Advisory Committee on the Medical Use of Isotopes (ACMUI)
Richard Green, BSPharm, RPh, BCNP FAPhA,
Upon completion of this activity, participants will be able to: Discuss the ACMUI role in the NRC; Describe the current make-up of the ACMUI membership; Discuss the topics recently taken up by the ACMUI; Identify areas of future NRC action as a result of ACMUI reports.
UAN: 0675-0000-24-036-H03-P/T
Radiotherapeutics: Best Practice and Updates
Akram Hussein, PharmD, MBA, BCNP, Director – Nuclear Medicine Radiopharmacy, MD Anderson Cancer Center
Upon completion of this activity, participants will be able to: Describe the tools and infrastructure needed for a successful radiotherapeutics program; Discuss how a commercial and hospital nuclear pharmacist can support a theranostics center; Explain medical events related to radiotherapies and how to decrease their occurrence.
UAN: 0675-0000-24-037-H01-P/T
Instrument Review and Best Practices for Nuclear Pharmacy
Wendy Galbraith, PharmD, FAPhA, BCNP, Clinical Associate Professor, University of Oklahoma, Dept. of Pharmaceutical Sciences, College of Pharmacy, Nuclear Pharmacy & Research Imaging Facility
Upon completion of this activity, participants will be able to: Describe National Institute of Standards and Technology primary and secondary sources; Explain the error rate in measuring activity from various radiopharmaceuticals; Describe how to change or add a new calibration setting on the dose calibrators.
UAN: 0675-0000-24-038-H01-P/T
No Comments